chr16-70660067-C-T
Position:
Variant summary
Our verdict is Benign. Variant got -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BS1BS2
The NM_001393494.1(IL34):c.609C>T(p.Pro203=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00111 in 1,613,784 control chromosomes in the GnomAD database, including 23 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).
Frequency
Genomes: 𝑓 0.0058 ( 13 hom., cov: 33)
Exomes 𝑓: 0.00062 ( 10 hom. )
Consequence
IL34
NM_001393494.1 synonymous
NM_001393494.1 synonymous
Scores
2
Clinical Significance
Conservation
PhyloP100: 0.312
Genes affected
IL34 (HGNC:28529): (interleukin 34) Interleukin-34 is a cytokine that promotes the differentiation and viability of monocytes and macrophages through the colony-stimulating factor-1 receptor (CSF1R; MIM 164770) (Lin et al., 2008 [PubMed 18467591]).[supplied by OMIM, May 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Benign. Variant got -21 ACMG points.
BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.71).
BP6
Variant 16-70660067-C-T is Benign according to our data. Variant chr16-70660067-C-T is described in ClinVar as [Benign]. Clinvar id is 786945.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=0.312 with no splicing effect.
BS1
Variant frequency is greater than expected in population afr. gnomad4 allele frequency = 0.00583 (888/152246) while in subpopulation AFR AF= 0.0197 (819/41540). AF 95% confidence interval is 0.0186. There are 13 homozygotes in gnomad4. There are 432 alleles in male gnomad4 subpopulation. Median coverage is 33. This position pass quality control queck.
BS2
High Homozygotes in GnomAd4 at 13 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
IL34 | NM_001393494.1 | c.609C>T | p.Pro203= | synonymous_variant | 6/6 | ENST00000288098.7 | NP_001380423.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
IL34 | ENST00000288098.7 | c.609C>T | p.Pro203= | synonymous_variant | 6/6 | 1 | NM_001393494.1 | ENSP00000288098 | P2 | |
IL34 | ENST00000566361.1 | c.534C>T | p.Pro178= | synonymous_variant | 6/6 | 1 | ENSP00000463886 | A2 | ||
IL34 | ENST00000429149.6 | c.609C>T | p.Pro203= | synonymous_variant | 7/7 | 5 | ENSP00000397863 | P2 |
Frequencies
GnomAD3 genomes AF: 0.00583 AC: 887AN: 152128Hom.: 13 Cov.: 33
GnomAD3 genomes
AF:
AC:
887
AN:
152128
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00157 AC: 394AN: 250334Hom.: 3 AF XY: 0.00121 AC XY: 164AN XY: 135342
GnomAD3 exomes
AF:
AC:
394
AN:
250334
Hom.:
AF XY:
AC XY:
164
AN XY:
135342
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000622 AC: 909AN: 1461538Hom.: 10 Cov.: 33 AF XY: 0.000542 AC XY: 394AN XY: 727086
GnomAD4 exome
AF:
AC:
909
AN:
1461538
Hom.:
Cov.:
33
AF XY:
AC XY:
394
AN XY:
727086
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00583 AC: 888AN: 152246Hom.: 13 Cov.: 33 AF XY: 0.00580 AC XY: 432AN XY: 74438
GnomAD4 genome
AF:
AC:
888
AN:
152246
Hom.:
Cov.:
33
AF XY:
AC XY:
432
AN XY:
74438
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
Asia WGS
AF:
AC:
3
AN:
3478
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Benign
Submissions summary: Benign:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not provided Benign:2
Benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Apr 10, 2018 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
CADD
Benign
DANN
Benign
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at